Severe combined immunodeficiency: Otolaryngological presentation and management

Annals of Otology, Rhinology and Laryngology

Volumn 108, Issue 4 I, 1999, Pages 403-407

  Stocks, Rose Mary S ^a,b,d   Thompson, Jerome W ^a,b   Kun, Sheila ^c   Church, Joseph A ^c   Simms, Erin ^a,b  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b LE BONHEUR CHILDREN S HOSPITAL   (United States)

^c CHILDREN S HOSPITAL LOS ANGELES   (United States)

^d NONE   (United States)

Author keywords

Abscess; Mastoiditis; Severe combined immunodeficiency syndrome

Indexed keywords

ABSCESS; ARTICLE; B LYMPHOCYTE; CLINICAL ARTICLE; CLINICAL FEATURE; COMBINED IMMUNODEFICIENCY; COUGHING; FEMALE; HUMAN; INFANT; LYMPHOCYTE FUNCTION; MALE; MASTOIDITIS; MOUTH ULCER; NECK; NEWBORN; OTITIS MEDIA; OTORHINOLARYNGOLOGY; PHARYNGITIS; PRIORITY JOURNAL; RECURRENT INFECTION; RETROSPECTIVE STUDY; T LYMPHOCYTE; THRUSH; UPPER RESPIRATORY TRACT INFECTION; X CHROMOSOMAL INHERITANCE;

EID: 0032899413     PISSN: 00034894     EISSN: None     Source Type: Journal    
DOI: 10.1177/000348949910800415     Document Type: Article

References (14)

1. Shyur SD, Hill H. Immunodeficiency in the 1990s. Pediatr Infect Dis J 1991;10:595-611.
2. Harris JP, South MA. Immunodeficiency diseases: head and neck manifestations. Head Neck Surg 1982;5:114-24.
3. Shyur S, Hill HR. Recent advances in the genetics of primary immunodeficiency syndromes. J Pediatr 1996;129:8-24.
4. Buckley RH, Schiff RI, Schiff SE, et al. Human severe combined immunodeficiency: genetic, phenotypic, and functional diversity in one hundred eight infants. J Pediatr 1997;130: 378-87.
5. WHO Scientific Group. Primary immunodeficiency diseases; report of a WHO scientific group. Clin Exp Immunol 1995;99:1-24.
6. Abbas AK, Lichtman AH, Pober JS. Cellular and molecular immunology. Philadelphia, Pa: WB Saunders, 1994:411-29.
7. Stephan JL, Vlekova V, Le Deist F, et al. Severe combined immunodeficiency: a retrospective single-center study of clinical presentation and outcome in 117 patients. J Pediatr 1993;123:564-72.
8. Puck JM. Prenatal diagnosis and genetic analysis of X-linked immunodeficiency disorders. Pediatr Res 1993;33(suppl):S29-S34.
9. Noonan NA, Senner AM. Gene therapy techniques in the treatment of adenosine deaminase deficiency-severe combined deficiency syndrome. J Perinat Neonatal Nurs 1994;7:65-78.
10. Nelson DM, Butters KA, Markert ML, Reinsmoen NL, McIvor RS. Correction of proliferative responses in purine nucleoside phosphorylase (PNP)-deficient T lymphocytes by retroviral-mediated PNP gene transfer and expression. J Immunol 1995;154:3006-14.
11. Markert ML, Hershfield MS, Schiff RI, Buckley RH. Adenosine deaminase and purine nucleoside phosphorylase deficiencies: evaluation of therapeutic intervention in eight patients. J Clin Immunol 1987;7:389-99.
12. Locksley RM, Wilson CB. Cell mediated immunity and its role in host defense. In: Mandel GI, ed. Principles and practices of infectious diseases. 4th ed. New York, NY: Churchill Livingstone, 1995:102-48.
13. Jones KL. Osteochondrodysplasia. In: Smith's recognizable patterns of human malformation. 5th ed. Philadelphia, Pa: WB Saunders, 1997:384-5.
14. McKusick VA. Autosomal recessive phenotypes. In: Francomano CA, Antonarakis SE, Pearson PL, eds. Mendelian inheritance in man. 9th ed. Baltimore, Md: Johns Hopkins Press, 1995:1322-3.